Preoperative sintilimab plus transarterial chemoembolization for hepatocellular carcinoma exceeding the Milan criteria: A phase II trial.

Chengxiang Guo Junlei Zhang Xin Huang Yiwen Chen Jianpeng Sheng Xing Huang Jun-Hui Sun Wen-Bo Xiao Ke Sun Shunliang Gao Risheng Que Yan Shen Min Zhang Jian Wu Xue-Li Bai Jianpeng Sheng

Published in: Hepatology communications (2023)

Sintilimab plus DEB-TACE before surgery showed good efficacy and safety in patients with HCC of BCLC stage A exceeding the Milan criteria or BCLC stage B.

Keyphrases

minimally invasive
radiofrequency ablation
coronary artery bypass
patients undergoing
open label
clinical trial
liver metastases
acute coronary syndrome
percutaneous coronary intervention